We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$52.1B
AUM Growth
+$2.17B
(+4.3%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
2,874
New
70
Increased
1,157
Reduced
1,512
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$509M |
| 2 |
Amazon
AMZN
|
+$505M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$337M |
| 4 |
Netflix
NFLX
|
+$286M |
| 5 |
Palo Alto Networks
PANW
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$960M |
| 2 |
Visa
V
|
+$600M |
| 3 |
PayPal
PYPL
|
+$296M |
| 4 |
Autodesk
ADSK
|
+$249M |
| 5 |
Nike
NKE
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.49% |
| 2 | Consumer Discretionary | 13.74% |
| 3 | Healthcare | 12.67% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Tredegar Corp
TG
$281M
| $126K | ﹤0.01% |
10,646
-219
| -2% | -$2.64K |
|
2627
Viking Therapeutics
VKTX
$3.97B
| $126K | ﹤0.01% |
27,389
-964
| -3% | -$5.4K |
|
2628
Eos Energy Enterprises
EOSE
$1.51B
| $125K | ﹤0.01% |
16,681
-408
| -2% | -$4.14K |
|
|
BDSI
2629
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $125K | ﹤0.01% |
40,254
-2,029
| -5% | -$6.83K |
|
2630
Citizens
CIA
$199M
| $124K | ﹤0.01% |
23,444
-438
| -2% | -$2.68K |
|
2631
Lifecore Biomedical
LFCR
$181M
| $124K | ﹤0.01% |
11,188
-709
| -6% | -$6.88K |
|
|
PRVB
2632
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $124K | ﹤0.01% |
22,082
-143
| -0.6% | -$908 |
|
|
TCS
2633
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $123K | ﹤0.01% |
822
-49
| -6% | -$8.28K |
|
2634
Radiant Logistics
RLGT
$400M
| $122K | ﹤0.01% |
16,787
+202
| +1% | +$1.45K |
|
2635
RPC Inc
RES
$1.4B
| $121K | ﹤0.01% |
26,726
-809
| -3% | -$3.97K |
|
2636
Arbutus Biopharma
ABUS
$908M
| $120K | ﹤0.01% |
30,937
-905
| -3% | -$3.52K |
|
2637
CleanSpark
CLSK
$2.96B
| $120K | ﹤0.01% |
12,647
-299
| -2% | -$4.78K |
|
2638
Kopin
KOPN
$898M
| $120K | ﹤0.01% |
29,396
-905
| -3% | -$4.6K |
|
|
LITS
2639
Lite Strategy Inc
LITS
$31.4M
| $119K | ﹤0.01% |
2,229
-173
| -7% | -$9.65K |
|
|
AERI
2640
DELISTED
Aerie Pharmaceuticals
AERI
| $118K | ﹤0.01% |
16,791
-184,032
| -92% | -$1.93M |
|
2641
Standard BioTools
LAB
$312M
| $117K | ﹤0.01% |
29,813
-898
| -3% | -$4.2K |
|
2642
Oil States International
OIS
$536M
| $117K | ﹤0.01% |
23,563
-42,382
| -64% | -$249K |
|
2643
Lineage Cell Therapeutics
LCTX
$268M
| $116K | ﹤0.01% |
47,315
-655
| -1% | -$1.53K |
|
2644
Cartesian Therapeutics
RNAC
$262M
| $116K | ﹤0.01% |
1,190
-11
| -0.9% | -$1.18K |
|
|
AUD
2645
DELISTED
Audacy, Inc.
AUD
| $116K | ﹤0.01% |
45,297
-4,382
| -9% | -$13.5K |
|
2646
Aveanna Healthcare
AVAH
$1.97B
| $115K | ﹤0.01% |
15,544
-191
| -1% | -$1.39K |
|
2647
Lexicon Pharmaceuticals
LXRX
$1.05B
| $115K | ﹤0.01% |
29,176
+2,269
| +8% | +$11K |
|
2648
American Superconductor
AMSC
$1.56B
| $114K | ﹤0.01% |
10,436
-471
| -4% | -$6.79K |
|
2649
CytomX Therapeutics
CTMX
$760M
| $114K | ﹤0.01% |
26,331
-158
| -0.6% | -$926 |
|
|
AKTS
2650
DELISTED
Akoustis Technologies Inc
AKTS
| $114K | ﹤0.01% |
17,106
+4
| +0% | +$30 |
|
Similar funds
VOYA Investment Management's Q4 2021 Portfolio in Review
As of Q4 2021, VOYA Investment Management held 2,874 positions worth $52.1B, up 4.3% from $50B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
VOYA Investment Management withdrew a net $1.73B in Q4 2021, closing 101 positions and reducing 1,512 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $34.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, VOYA Investment Management opened a new position in iShares MSCI EAFE Small-Cap ETF worth $137M.
- VOYA Investment Management's largest Q4 2021 buy was iShares MSCI EAFE Small-Cap ETF: 1,871,171 shares worth $137M.
- VOYA Investment Management added most to NVIDIA in Q4 2021, an estimated $509M increase.
- VOYA Investment Management's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $960M.
- VOYA Investment Management fully exited iShares Core S&P 500 ETF in Q4 2021, selling an estimated $34.6M.
- VOYA Investment Management's ten largest holdings make up 23% of its $52.1B portfolio in Q4 2021.
- VOYA Investment Management opened 70 new positions and closed 101 in Q4 2021.
- VOYA Investment Management's portfolio value rose 4.3% quarter-over-quarter to $52.1B.
Based on VOYA Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.